November 28, 2016
Posted December 27, 2016
Iowa-based Hematology and Oncology Center of Iowa, P.C. and its only corporate officer, Dr. Magdy Elsawy, agreed to pay $176,460 to settle allegations that they violated the False Claims Act by submitting false billings for cancer drugs that were not approved, misbranded, or counterfeit, and by submitting office visit claims for visits that were either medically unnecessary or were upcoded to reflect more complex encounters than what actually happened. DOJ (NDIA)
Tagged in: FCA Federal, Healthcare Fraud,